Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study

Clinical trial NCT04447703 · COMPLETED

Trial details

NCT number: NCT04447703
Sponsor: Thomas Jefferson University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Biochemically Recurrent Prostate Carcinoma Metastatic Prostate Carcinoma Stage IIIB Prostate Cancer AJCC v8 Stage IIIC Prostate Cancer AJCC v8 Stage IV Prostate Cancer AJCC v8

Start date: 2020-08-27
Primary completion: 2022-08-09
Enrollment: 346

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.